379 related articles for article (PubMed ID: 26206334)
1. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
2. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
[TBL] [Abstract][Full Text] [Related]
3. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.
Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG
BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202
[TBL] [Abstract][Full Text] [Related]
4. A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.
Guo Y; Kenney SR; Cook L; Adams SF; Rutledge T; Romero E; Oprea TI; Sklar LA; Bedrick E; Wiggins CL; Kang H; Lomo L; Muller CY; Wandinger-Ness A; Hudson LG
Clin Cancer Res; 2015 Nov; 21(22):5064-72. PubMed ID: 26071482
[TBL] [Abstract][Full Text] [Related]
5. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
6. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
8. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
9. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42.
Nicola C; Lala PK; Chakraborty C
Biol Reprod; 2008 Jun; 78(6):976-82. PubMed ID: 18235104
[TBL] [Abstract][Full Text] [Related]
11. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
13. Dual Actions of Ketorolac in Metastatic Ovarian Cancer.
Hudson LG; Cook LS; Grimes MM; Muller CY; Adams SF; Wandinger-Ness A
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31344967
[TBL] [Abstract][Full Text] [Related]
14. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D
Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862
[TBL] [Abstract][Full Text] [Related]
15. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
Huang Q; Shen HM; Ong CN
Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
[TBL] [Abstract][Full Text] [Related]
16. Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
Díaz J; Mendoza P; Ortiz R; Díaz N; Leyton L; Stupack D; Quest AF; Torres VA
J Cell Sci; 2014 Jun; 127(Pt 11):2401-6. PubMed ID: 24659799
[TBL] [Abstract][Full Text] [Related]
17. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
18. Activation of Dbl restores migration in polyamine-depleted intestinal epithelial cells via Rho-GTPases.
Ray RM; Bavaria MN; Bhattacharya S; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G988-97. PubMed ID: 21372162
[TBL] [Abstract][Full Text] [Related]
19. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
20. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3.
Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
